Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
QuintilesIMS
US Army
Moodys
AstraZeneca
Harvard Business School
Johnson and Johnson
Mallinckrodt

Generated: May 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: topotecan hydrochloride

« Back to Dashboard

topotecan hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp HYCAMTIN topotecan hydrochloride CAPSULE;ORAL 020981 NDA Novartis Pharmaceuticals Corporation N 0078-0672-01
Novartis Pharms Corp HYCAMTIN topotecan hydrochloride CAPSULE;ORAL 020981 NDA Novartis Pharmaceuticals Corporation N 0078-0673-01
Novartis Pharms Corp HYCAMTIN topotecan hydrochloride INJECTABLE;INJECTION 020671 NDA GlaxoSmithKline LLC N 0007-4201-01
Novartis Pharms Corp HYCAMTIN topotecan hydrochloride INJECTABLE;INJECTION 020671 NDA Novartis Pharmaceuticals Corporation N 0078-0674-61
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Harvard Business School
McKinsey
US Department of Justice
Fuji
Deloitte
Julphar
Chinese Patent Office